Clinical Trial

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
Sponsor/Funder decision
Summary
This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.
Protocol Amendment History 3 changes
critical Withdrawn before enrolling 2026-08-05
critical Trial withdrawn: Sponsor/Funder decision 2026-08-05
notable Enrollment reduced: 400 -> 0 participants 2026-08-05
Trial Details
NCT Number NCT07075627
Lead Sponsor Addario Lung Cancer Medical Institute
Conditions Small Cell Lung Cancer ( SCLC ), Lambert Eaton Myasthenic Syndrome (LEMS)
Start Date 2025-09
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-04